Theophylline as a Treatment for Children With Pseudohypoparathyroidism Type 1a (Albright Hereditary Osteodystrophy)



Status:Recruiting
Conditions:Endocrine, Endocrine
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:10 - 21
Updated:7/1/2016
Start Date:June 2015
End Date:August 2016
Contact:Ashley H Shoemaker, MD, MSCI
Email:Ashley.H.Shoemaker@Vanderbilt.edu
Phone:615-343-8116

Use our guide to learn which trials are right for you!

Effects of Theophylline on cAMP Signaling in Children With Pseudohypoparathyroidism Type 1a

This study will test an investigational drug, theophylline, in children with
pseudohypoparathyroidism type 1a (PHP1a). This study involves a 3 day visit to the
Vanderbilt Clinical Research Center.


Inclusion Criteria:

1. Age 10 to 21 years old

2. English proficiency

3. Clinical and genetic diagnosis of PHP1a

Exclusion Criteria:

1. Use of a PDE inhibitor in the past 30 days

2. History of a seizure disorder unrelated to hypocalcemia

3. History of a cardiac arrhythmia (not including bradycardia)

4. History of hepatic insufficiency

5. AST or ALT >2x upper limit of normal

6. Total bilirubin >1.5 x upper limit of normal (unless patient has a diagnosis of
Gilbert's syndrome and no other causes leading to hyperbilirubinemia are identified)

7. Congestive heart failure

8. Cigarette use in the past 30 days

9. Alcohol use within the past 24 hours

10. Current pregnancy

11. Untreated hypothyroidism (defined as free T4 level < 0.6 ng/dL or TSH >10 mcU/mL)

12. Active peptic ulcer disease

13. Fever >101 degrees in the past 24 hours

14. Current use of medications known to effect theophylline levels (listed below)

15. Severe sleep apnea requiring BiPAP

Drugs with clinically significant drug interactions with theophylline:

- Allopurinol

- Cimetidine

- Ciprofloxacin

- Clarithromycin

- Enoxacin

- Ephedrine

- Erythromycin

- Estrogen

- Flurazepam

- Fluvoxamine

- Lithium

- Lorazepam

- Methotrexate

- Midazolam

- Pentoxifylline

- Propranolol

- Rifampin

- Sulfinpyrazone

- Tacrine

- Thiabendazole

- Ticlopidine

- Troleandomycin

- Verapamil
We found this trial at
1
site
1211 Medical Center Drive
Nashville, Tennessee 37232
Principal Investigator: Ashley Shoemaker, MD
Phone: 615-343-8116
?
mi
from
Nashville, TN
Click here to add this to my saved trials